Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
Status: Enrolling
Updated:  12/31/1969
AZ Sint-Jan
mi
from
Brugge,
Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
Status: Enrolling
Updated: 12/31/1969
AZ Sint-Jan
mi
from
Brugge,
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
DilaCheck Cervical Dilation Measurement Trial
Inter-examiner Agreement of a Novel Device for the Measurement of Cervical Dilation in Labor: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
DilaCheck Cervical Dilation Measurement Trial
Inter-examiner Agreement of a Novel Device for the Measurement of Cervical Dilation in Labor: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Tobacco Use in Pregnancy Intervention for Cessation
Tobacco Use in Pregnancy Intervention for Cessation
Status: Enrolling
Updated:  12/31/1969
University of Kentucky, College of Nursing
mi
from
Lexington, KY
Tobacco Use in Pregnancy Intervention for Cessation
Tobacco Use in Pregnancy Intervention for Cessation
Status: Enrolling
Updated: 12/31/1969
University of Kentucky, College of Nursing
mi
from
Lexington, KY
Click here to add this to my saved trials
Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
Status: Enrolling
Updated:  12/31/1969
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
Status: Enrolling
Updated: 12/31/1969
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
A Randomized Study to Evaluate the Effect of Outpatient Symptom Management on Symptom Burden in Advanced Stage or Recurrent Gynecologic Oncology Patients Receiving Chemotherapy
Status: Enrolling
Updated:  12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
A Randomized Study to Evaluate the Effect of Outpatient Symptom Management on Symptom Burden in Advanced Stage or Recurrent Gynecologic Oncology Patients Receiving Chemotherapy
Status: Enrolling
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Monitoring Movement and Health Study
Sedentary Behavior in Pregnancy and Cardiovascular Health: the Monitoring Movement and Health (MoM Health) Study
Status: Enrolling
Updated:  12/31/1969
Physical Activity and Weight Management Research Center
mi
from
Pittsburgh, PA
Monitoring Movement and Health Study
Sedentary Behavior in Pregnancy and Cardiovascular Health: the Monitoring Movement and Health (MoM Health) Study
Status: Enrolling
Updated: 12/31/1969
Physical Activity and Weight Management Research Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Strategies for Pregnancy Achievement
Strategies for Pregnancy Achievement (SPA): a Pilot Study
Status: Enrolling
Updated:  12/31/1969
The Ohio State University College of Medicine
mi
from
Columbus, OH
Strategies for Pregnancy Achievement
Strategies for Pregnancy Achievement (SPA): a Pilot Study
Status: Enrolling
Updated: 12/31/1969
The Ohio State University College of Medicine
mi
from
Columbus, OH
Click here to add this to my saved trials
Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis
A Multicenter, Randomized, Double-Blind, Vehicle Controlled Study Evaluating the Therapeutic Equivalence and Safety of GDC-229 (Investigational Metronidazole 0.75% Vaginal Gel) and Metronidazole 0.75% Vaginal Gel in the Treatment of Bacterial Vaginosis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis
A Multicenter, Randomized, Double-Blind, Vehicle Controlled Study Evaluating the Therapeutic Equivalence and Safety of GDC-229 (Investigational Metronidazole 0.75% Vaginal Gel) and Metronidazole 0.75% Vaginal Gel in the Treatment of Bacterial Vaginosis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Pregnancy Outcomes After Uterine Cavity Expansion
Pregnancy Outcomes Following Hysteroscopic Expansion of the Uterine Cavity for Patients With Small Cavities and Poor Reproductive Outcomes
Status: Enrolling
Updated:  12/31/1969
Reproductive Medicine Associates of New Jersey
mi
from
Basking Ridge, NJ
Pregnancy Outcomes After Uterine Cavity Expansion
Pregnancy Outcomes Following Hysteroscopic Expansion of the Uterine Cavity for Patients With Small Cavities and Poor Reproductive Outcomes
Status: Enrolling
Updated: 12/31/1969
Reproductive Medicine Associates of New Jersey
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population
Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population
Status: Enrolling
Updated:  12/31/1969
University of Texas Medical Branch
mi
from
Galveston, TX
Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population
Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population
Status: Enrolling
Updated: 12/31/1969
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Apical Support During Hysterectomy for Pelvic Organ Prolapse-NSQIP Analysis.
Are we Supporting the Apex During Hysterectomy for Pelvic Organ Prolapse: A NSQIP Analysis.
Status: Enrolling
Updated:  12/31/1969
TriHealth - Cincinnati Urogynecology Associates
mi
from
Cincinnati, OH
Apical Support During Hysterectomy for Pelvic Organ Prolapse-NSQIP Analysis.
Are we Supporting the Apex During Hysterectomy for Pelvic Organ Prolapse: A NSQIP Analysis.
Status: Enrolling
Updated: 12/31/1969
TriHealth - Cincinnati Urogynecology Associates
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Lavender During Intrauterine Insemination
Lavender Aromatherapy vs Placebo to Decrease Anxiety and Pain During Intrauterine Insemination (IUI).
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Lavender During Intrauterine Insemination
Lavender Aromatherapy vs Placebo to Decrease Anxiety and Pain During Intrauterine Insemination (IUI).
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
In-use Study of Four Different Tampons
In-use Randomized, Cross-over, Controlled Double-blind Study of Four Different Tampons
Status: Enrolling
Updated:  12/31/1969
Synexus-US
mi
from
Cincinnati, OH
In-use Study of Four Different Tampons
In-use Randomized, Cross-over, Controlled Double-blind Study of Four Different Tampons
Status: Enrolling
Updated: 12/31/1969
Synexus-US
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test
Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes
Status: Enrolling
Updated:  12/31/1969
Good Samaritan Hospital
mi
from
Long Beach, CA
Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test
Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes
Status: Enrolling
Updated: 12/31/1969
Good Samaritan Hospital
mi
from
Long Beach, CA
Click here to add this to my saved trials
Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test
Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes
Status: Enrolling
Updated:  12/31/1969
Willis Knighton
mi
from
Shreveport, LA
Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test
Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes
Status: Enrolling
Updated: 12/31/1969
Willis Knighton
mi
from
Shreveport, LA
Click here to add this to my saved trials
Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test
Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes
Status: Enrolling
Updated:  12/31/1969
Rutgers
mi
from
Newark, NJ
Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test
Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes
Status: Enrolling
Updated: 12/31/1969
Rutgers
mi
from
Newark, NJ
Click here to add this to my saved trials
Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test
Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes
Status: Enrolling
Updated:  12/31/1969
The Ohio State Medical Center
mi
from
Columbus, OH
Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test
Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes
Status: Enrolling
Updated: 12/31/1969
The Ohio State Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test
Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes
Status: Enrolling
Updated:  12/31/1969
Regional Obstetrical Consultants
mi
from
Chattanooga, TN
Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test
Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes
Status: Enrolling
Updated: 12/31/1969
Regional Obstetrical Consultants
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of California-Davis
mi
from
Sacramento, CA
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Washington University
mi
from
Saint Louis, MO
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Nemours Children's Hospital
mi
from
Orlando, FL
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Nemours Children's Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of Iowa Stead Family Children's Hospital
mi
from
Iowa City, IA
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Iowa Stead Family Children's Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Children's/ UT Southwestern Medical Center
mi
from
Dallas, TX
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Children's/ UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of Massachusetts Medical Center
mi
from
Worcester, MA
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Massachusetts Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Ronald Reagan UCLA Medical Center
mi
from
Los Angeles, CA
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Ronald Reagan UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Family Planning Ahead
Family Planning Ahead
Status: Enrolling
Updated:  12/31/1969
Internet (Dartmouth College)
mi
from
Lebanon, NH
Family Planning Ahead
Family Planning Ahead
Status: Enrolling
Updated: 12/31/1969
Internet (Dartmouth College)
mi
from
Lebanon, NH
Click here to add this to my saved trials
Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects
Clinical Study Evaluating the Safety of PregSense and Comparative Performance of PregSense Versus CTG in Prenatal Monitoring of Pregnant Subjects
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects
Clinical Study Evaluating the Safety of PregSense and Comparative Performance of PregSense Versus CTG in Prenatal Monitoring of Pregnant Subjects
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects
Clinical Study Evaluating the Safety of PregSense and Comparative Performance of PregSense Versus CTG in Prenatal Monitoring of Pregnant Subjects
Status: Enrolling
Updated:  12/31/1969
Eastern Virginia Medical School
mi
from
Norfolk, VA
Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects
Clinical Study Evaluating the Safety of PregSense and Comparative Performance of PregSense Versus CTG in Prenatal Monitoring of Pregnant Subjects
Status: Enrolling
Updated: 12/31/1969
Eastern Virginia Medical School
mi
from
Norfolk, VA
Click here to add this to my saved trials
Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects
Clinical Study Evaluating the Safety of PregSense and Comparative Performance of PregSense Versus CTG in Prenatal Monitoring of Pregnant Subjects
Status: Enrolling
Updated:  12/31/1969
Heidelberg University Womens Hospital
mi
from
Heidelberg,
Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects
Clinical Study Evaluating the Safety of PregSense and Comparative Performance of PregSense Versus CTG in Prenatal Monitoring of Pregnant Subjects
Status: Enrolling
Updated: 12/31/1969
Heidelberg University Womens Hospital
mi
from
Heidelberg,
Click here to add this to my saved trials
Honduras Liger Thermocoagulator Study
Evaluation of the Liger Medical Thermocoagulator for Treatment of Cervical Intraepithelial Lesions in Honduras
Status: Enrolling
Updated:  12/31/1969
PATH
mi
from
Seattle, WA
Honduras Liger Thermocoagulator Study
Evaluation of the Liger Medical Thermocoagulator for Treatment of Cervical Intraepithelial Lesions in Honduras
Status: Enrolling
Updated: 12/31/1969
PATH
mi
from
Seattle, WA
Click here to add this to my saved trials
Development of the ERA-Microbiome Non-invasive Diagnosis Tool
Development of a Non-invasive Diagnosis Tool for the Simultaneous Analysis of Endometrial Receptivity and Microbiota to Improve Reproductive Outcomes in Infertile Patients.
Status: Enrolling
Updated:  12/31/1969
RMA Connecticut
mi
from
Norwalk, CT
Development of the ERA-Microbiome Non-invasive Diagnosis Tool
Development of a Non-invasive Diagnosis Tool for the Simultaneous Analysis of Endometrial Receptivity and Microbiota to Improve Reproductive Outcomes in Infertile Patients.
Status: Enrolling
Updated: 12/31/1969
RMA Connecticut
mi
from
Norwalk, CT
Click here to add this to my saved trials
Development of the ERA-Microbiome Non-invasive Diagnosis Tool
Development of a Non-invasive Diagnosis Tool for the Simultaneous Analysis of Endometrial Receptivity and Microbiota to Improve Reproductive Outcomes in Infertile Patients.
Status: Enrolling
Updated:  12/31/1969
Ivf Florida
mi
from
Margate, FL
Development of the ERA-Microbiome Non-invasive Diagnosis Tool
Development of a Non-invasive Diagnosis Tool for the Simultaneous Analysis of Endometrial Receptivity and Microbiota to Improve Reproductive Outcomes in Infertile Patients.
Status: Enrolling
Updated: 12/31/1969
Ivf Florida
mi
from
Margate, FL
Click here to add this to my saved trials
Development of the ERA-Microbiome Non-invasive Diagnosis Tool
Development of a Non-invasive Diagnosis Tool for the Simultaneous Analysis of Endometrial Receptivity and Microbiota to Improve Reproductive Outcomes in Infertile Patients.
Status: Enrolling
Updated:  12/31/1969
Missouri Center for Reproductive Medicine (MCRM Fertility)
mi
from
Chesterfield, MO
Development of the ERA-Microbiome Non-invasive Diagnosis Tool
Development of a Non-invasive Diagnosis Tool for the Simultaneous Analysis of Endometrial Receptivity and Microbiota to Improve Reproductive Outcomes in Infertile Patients.
Status: Enrolling
Updated: 12/31/1969
Missouri Center for Reproductive Medicine (MCRM Fertility)
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Development of the ERA-Microbiome Non-invasive Diagnosis Tool
Development of a Non-invasive Diagnosis Tool for the Simultaneous Analysis of Endometrial Receptivity and Microbiota to Improve Reproductive Outcomes in Infertile Patients.
Status: Enrolling
Updated:  12/31/1969
Dominion Fertility
mi
from
Arlington, WA
Development of the ERA-Microbiome Non-invasive Diagnosis Tool
Development of a Non-invasive Diagnosis Tool for the Simultaneous Analysis of Endometrial Receptivity and Microbiota to Improve Reproductive Outcomes in Infertile Patients.
Status: Enrolling
Updated: 12/31/1969
Dominion Fertility
mi
from
Arlington, WA
Click here to add this to my saved trials
Development of the ERA-Microbiome Non-invasive Diagnosis Tool
Development of a Non-invasive Diagnosis Tool for the Simultaneous Analysis of Endometrial Receptivity and Microbiota to Improve Reproductive Outcomes in Infertile Patients.
Status: Enrolling
Updated:  12/31/1969
Gestanza Medicina Reproductiva
mi
from
Rosario,
Development of the ERA-Microbiome Non-invasive Diagnosis Tool
Development of a Non-invasive Diagnosis Tool for the Simultaneous Analysis of Endometrial Receptivity and Microbiota to Improve Reproductive Outcomes in Infertile Patients.
Status: Enrolling
Updated: 12/31/1969
Gestanza Medicina Reproductiva
mi
from
Rosario,
Click here to add this to my saved trials
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study (TAPPAS): A Randomized, Placebo-controlled Double Blind Trial
Status: Enrolling
Updated:  12/31/1969
Community Regional Medical Center
mi
from
Fresno, CA
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study (TAPPAS): A Randomized, Placebo-controlled Double Blind Trial
Status: Enrolling
Updated: 12/31/1969
Community Regional Medical Center
mi
from
Fresno, CA
Click here to add this to my saved trials
CALM for Pregnant and Post-Partum Women
A Randomized Controlled Trial of Coordinated Anxiety Learning and Management (CALM) for Pregnant and Postpartum Women
Status: Enrolling
Updated:  12/31/1969
University of California, San Francisco
mi
from
Oakland, CA
CALM for Pregnant and Post-Partum Women
A Randomized Controlled Trial of Coordinated Anxiety Learning and Management (CALM) for Pregnant and Postpartum Women
Status: Enrolling
Updated: 12/31/1969
University of California, San Francisco
mi
from
Oakland, CA
Click here to add this to my saved trials
Systems of Care for New Moms: Integrating Depression Treatment
Systems of Care for New Moms: Integrating Depression Treatment
Status: Enrolling
Updated:  12/31/1969
Washington University and Nurses for Newborns Foundations
mi
from
Saint Louis, MO
Systems of Care for New Moms: Integrating Depression Treatment
Systems of Care for New Moms: Integrating Depression Treatment
Status: Enrolling
Updated: 12/31/1969
Washington University and Nurses for Newborns Foundations
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
Status: Enrolling
Updated:  12/31/1969
International Research Partners, LLC.
mi
from
Doral, FL
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
Status: Enrolling
Updated: 12/31/1969
International Research Partners, LLC.
mi
from
Doral, FL
Click here to add this to my saved trials
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
Status: Enrolling
Updated:  12/31/1969
Prism Clinical Research
mi
from
Saint Paul, MN
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
Status: Enrolling
Updated: 12/31/1969
Prism Clinical Research
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
Randomized Controlled Trial Comparing EmbryoScope Time-Lapse System With the New Model EmbryoScope+.
Status: Enrolling
Updated:  12/31/1969
Center for Reproductive Medicine
mi
from
New York, NY
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
Randomized Controlled Trial Comparing EmbryoScope Time-Lapse System With the New Model EmbryoScope+.
Status: Enrolling
Updated: 12/31/1969
Center for Reproductive Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Impact of Escitalopram on Sperm DNA Fragmentation
Assessing the Impact of Escitalopram on Sperm DNA Fragmentation: A Randomized Placebo Controlled
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medicine
mi
from
New York, NY
Impact of Escitalopram on Sperm DNA Fragmentation
Assessing the Impact of Escitalopram on Sperm DNA Fragmentation: A Randomized Placebo Controlled
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medicine
mi
from
New York, NY
Click here to add this to my saved trials
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
SGN-00101 (HspE7) Immunotherapy Of CIN III
Status: Enrolling
Updated:  12/31/1969
Albert Einstein Cancer Center at Albert Einstein College of Medicine
mi
from
Bronx, NY
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
SGN-00101 (HspE7) Immunotherapy Of CIN III
Status: Enrolling
Updated: 12/31/1969
Albert Einstein Cancer Center at Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
SGN-00101 (HspE7) Immunotherapy Of CIN III
Status: Enrolling
Updated:  12/31/1969
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
SGN-00101 (HspE7) Immunotherapy Of CIN III
Status: Enrolling
Updated: 12/31/1969
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
Click here to add this to my saved trials